Introduction
Hydrogel matrices have been gaining relevance throughout the years as drug delivery systems or even as medical devices. 1, 2 This is due mainly to their hydrophilicity, their biocompatibility and their drug loading and release promising properties. Hydrogels can be loaded with a drug or an active substance and be implanted into a patient enabling a controlled drug release. Another type of hydrogels is in situ gelling systems. They possess new promising properties such as a fast degradation process or the capability of forming the gel where it is needed by physical crosslinking between different molecules. In this process of gelation, a protein, a peptide or a drug can be added to the mixture before the crosslinking takes place, so it will finally get immobilised inside the bulk of the gel. [3] [4] [5] [6] [7] [8] This last property is very important because it allows us to inject the mixture inside a tissue using a simple needle without any kind of surgery. 9, 10 Selfassembled hydrogels constitute an important family of these in situ gelling systems.
These kind of hydrogels are supramolecular systems that are formed spontaneously when their constituents come into contact or else after a certain trigger such as temperature 10 PEO/PPO block copolymers can be employed as micellar nanocarriers for drug delivery due to their high solubilisation capacity and biocompatibility. These systems are not just inert carriers but they can act as biological response modifiers because they can induce certain cellular responses, such as inhibition of cell efflux transporters and ability to increase drug transport across membranes, which can be advantageous from the therapeutic point of view. [13] [14] [15] As a matter of fact, poloxamines have been successfully employed in the preparation of different therapeutic systems, such as micellar drug carriers 16 and nanoparticles. 17, 18 In this sense, nanoparticle surface modification with poloxamines was found to determine the biological fate of certain carrier systems. In addition, these polymers have been applied in the field of injectable implants. 19 For instance, cytocompatible implantable matrices for sustained release of ciprofloxacin have been prepared using poli-ε-caprolactone/poloxamine blends. 20 Some of these amphiphilic copolymers can gelify by themselves in aqueous solutions under certain conditions. [16] [17] [18] [19] The addition of cyclodextrins (CDs) enhances the gelation process for PEO/PPO block copolymers, even to the point of making feasible the formation of gels with poloxamers or poloxamines that do not gelify by themselves. 202122 It has been shown that the addition of α-cyclodextrin (α-CD) to PEO-PPO solutions leads to the formation of inclusion complexes between α-CD and the PEO blocks with a polypseudorotaxane structure and the aggregation between uncomplexed PPO blocks by hydrophobic interactions, yielding gels. 20, 21, 9, 23 Diverse types of hydrogels based on cyclodextrins have been prepared previously. 24, 25 Nevertheless, those were chemically crosslinked gels, so the in situ physical hydrogels formed with CD and PEO/PPO block copolymers are a good alternative. Recently, polypseudorotaxanes made of a normal Tetronic (T908) and α-CD have been used to prepare syringeable viscoelastic gels. Besides a good compatibility, these materials combined with simvastatin showed an intrinsic ability to promote osteoblast differentiation. 31 In the present study, an in situ hydrogel prepared using α-CD and the reverse Tetronic 90R4 (90R4) was evaluated as a drug delivery device. The model molecules released from these gels were an aminoacid, L-Tryptophan (Trp), and a protein, bovine serum albumin (BSA). The 90R4/CD gels have proved to be erodible matrices, so they seem to be promising as drug release devices. 20 The release of Trp and BSA from these 90R4/CD matrices was evaluated using 90R4/CD hydrogels, and also with tablets made from these hydrogels. Different mathematical models were used in order to elucidate the mechanisms that predominate in the release processes from the tablets.
EXPERIMENTAL
Materials. Tetronic 90R4 (M w = 6900 g/mol) was kindly donated by BASF and it was used as received. This poloxamine is a yellow liquid (viscosity 3870 cP at 25ºC). The composition of the four blocks in the polymer, determined by 1 H-NMR (Bruker DPX 300 at 298 K), is PO 16 EO 18 per arm. α-CD was obtained from Wacker Chemie AG Cavamax® W6 Pharma Alfadex) and was used without further purifications. LTryptophan (Trp) and Bovine serum albumin (BSA) were purchased from SigmaAldrich and were used as received.
Gel formation. All complexes were prepared by mixing a determinate amount of the 90R4 poloxamine with an aqueous solution of α-CD followed by vigorous stirring.
Before using them, the resulting mixtures were kept at room temperature for at least one night. Some of the gels were loaded with Trp or BSA in order to perform release studies. These substances were previously dissolved in the α-CD solution before mixing it with the poloxamine.
Tablet preparation. The resulting gels were freeze dried and the obtained product was compressed using a Specac pellet die. The resulting tablets were weighed and measured prior to their use (see Results and Discussion section). The hardness of the obtained samples was measured using a Caleva Tablet Hardness Tester (see Supporting
Information for details). Freeze dried gels loaded with Trp or BSA were used to prepare tablets for release kinetics studies. Besides, additional tablets made from unloaded gels were used for the erosion kinetics analysis. Each BSA tablet contained 200 mg of the protein.
On the other hand, the Trp tablets contained 30 mg of the amino-acid for the tablets prepared using 15% (w/w) of Tetronic and 20 mg of the amino acid for the tablets prepared using 25% (w/w).
Tablet erosion studies. Seven unloaded tablets were placed into a SOTAX AT 7 Smart USP dissolution testing device at 37 ºC in 500 mL of pH 7 phosphate buffer medium; different experiments were performed using stirring speeds of 25 and 100 rpm. During the dissolution process, one tablet was removed from its vessel at different time intervals (see Supporting Information, Figure S1 ). These partially eroded tablets were placed in an oven at 37 ºC until constant weight. Using the initial weight of the tablet (W 0 ) and the weight after been eroded (W 1 ), the percentage of erosion at each time was calculated with the following equation (Eq 1):
In vitro release kinetics. The release studies were also performed from 500 mL of pH 7
phosphate buffer solutions using a SOTAX AT 7 Smart USP dissolution testing device at 37ºC at 25 rpm or 100 rpm stirring speeds. Samples ( The mobile phase was deionized water and the flow rate was 1 mL/min. The obtained value for the area under the curve for the samples was compared to standard solutions to obtain the concentration of α-CD. Different release experiments were carried out using gels and tablets. In order to study the release kinetics from the gels, they were formed at the bottom of the dissolution testing device vessels and the dissolution medium was added on top of them at the beginning of the release kinetics. An amount of 20 g of gel was used in each experiment. For the tablets, the standard measuring method was used:
the tablets were added into the vessels filled with the buffer media in order to start the release kinetic analyses. The experiments were performed in duplicate for the gels and in quadruplicate for the tablets. 
where j is the sample number, n is the number of dissolution sample times, is the time at the midpoint between In order to compare different release curves, the difference (f 1 ) and similarity factor (f 2 )
were calculated. 26 The difference factor (f 1 ) (Eq. 4) calculates the percent (%) difference between the two curves at each time point and is a measurement of the relative error between the two curves: where n is the number of time points, R is the dissolution value of the reference t (prechange) batch at time t, and T is the dissolution value of the test (postchange) batch at time t.
The similarity factor (f 2 ) (Eq. 5) is a logarithmic transformation of the sum-squared error of differences between the test Tj and reference products Rj over all time points, n.
The data obtained from the in vitro release experiments were fitted to different mathematical models of drug release. Several mechanisms are involved in drug release from hydrogel matrix systems: diffusion, swelling, and polymer erosion being the most important ones. Different mathematical models have been proposed to obtain information of the mechanisms, since it is difficult to develop a general expression suitable for every drug device. The most interesting models are the empirical/semiempirical ones, which provide an accurate fit to the experimental profiles (such as the Peppas equation and the Hopfenberg model), and the mechanistic realistic models, which give some insight into the real phenomena (such as those based on Fick's law). 33 The models used for this study were the Korsmeyer-Peppas equation (Eq. 6), the Higuchi equation (Eq. 7), the Peppas-Sahlin equations (Eq. 8a), the zero-order equation (Eq. 9a), the first-order equation (Eq.10) and the Hopfenberg equation (Eq. 11).
The Korsmeyer-Peppas model 27 is a simple semiempirical model which exponentially relates drug release with the elapsed time (Eq. 6).
where M t /M ∞ is the drug release fraction at time t, k KP is a constant incorporating the structural and geometric characteristics of the matrix tablets, and n is the release exponent indicative of the drug release mechanism. The value of n indicates the mechanism of the release. 27 If the value is around 0.5 (the exact value depends of the geometry) the mechanism is Case I (Fickian) diffusion and a value between 0.5 and 0.89 indicates anomalous (non-Fickian) diffusion. Values of n equal to 0.89 indicate Case II transport.
If the obtained release mechanism is mainly a Fickian diffusion, a dimensionless expression of the Higuchi model was used 26 
The zero-order kinetics equation (Eq 9a) was also used in order to evaluate the type of release mechanism. This model is used for systems where the matrix releases the same amount of drug by unit of time.
where Q t is the amount of drug dissolved in time t and Q 0 is the initial amount of drug in the solution (most times, Q 0 = 0) and K ZO is the zero order release constant. We have used a modified zero-order equation (Eq. 9b), where we have replaced the Q t term with
The first-order kinetics equation (Eq. 10) is shown below and describes the release of a drug in a way that is proportional to the amount of drug remaining in the interior of the matrix.
where Q t is the amount of drug dissolved in time t and Q 0 is the initial amount of drug and k FO is the first order release constant.
The evaluated tablets are eroded throughout the drug release process so a model that considers changes in the surface area of the matrix was used: a variation of the Hopfenberg model for tablets (Eq. 11).
Where M t /M ∞ is the drug release fraction at time t, C 0 is the initial concentration of drug in the tablet, a 0 and b 0 are the initial radius and thickness, respectively, and k HP is the erosion rate constant.
In order to fit the experimental data to the previous equations, only one portion of the release profile was used, i. 
RESULTS AND DISCUSSION
Release from gels. Gels prepared with Tetronic 90R4 and aqueous α-CD have been evaluated as release systems. These mixtures exhibit a pseudoplastic behaviour, i.e. the viscosity of the samples decreases when the shear rate is increased, and show an appropriate consistency. 20 Two different types of 90R4/α-CD gels were evaluated, namely T25a10 and T15a10 (Table 1 ). Figure 1 shows the release of BSA and Trp from T25a10 and T15a10 as a function of time at 37ºC in a pH 7 aqueous medium. The release process of BSA and Trp from T25a10 is faster than that of T15a10. This is consistent with the gel erosion studies performed by our group in a previous work. 20 Despite the significant differences in the amounts loaded and in the molecular sizes of both substrates, the release processes seem to be equivalent in both cases. In addition, the release of α-CD from the gels can be used as an indicator of the erosion kinetics of the matrix, because α-CD is one of the components of the gel structure.
The comparison between the release of α-CD and BSA is shown in Figure 2 . As can be seen, both profiles, i.e. those of the released molecule (BSA) and the ones related to the gel structure (α-CD), match each other. This indicates that the release of substances from these gels is dominated by the erosion of the gel matrix. Release from tablets. In order to investigate the mechanism of release from Tetronic 90R4 matrices, a controlled geometry was needed that allows us to apply different mathematical models. Cylindrical tablets were prepared by compressing freeze dried gels. Table 3 shows the size measurements and the composition of the tablets prepared in such a way.
Tablet erosion studies were carried out in order to compare these results with the release of α-CD from the tablet matrices ( Figure 3 ). The release profile for α-CD in T15a10 tablets and its erosion profile obtained by weighing the tablets as a function of time (see Experimental Part) are the same (Figure 3a) . Nevertheless, the release profile of α-CD from a BSA loaded T15a10 tablet is slightly faster than the erosion profile of the void tablets ( Figure 3b ). This can be due to fact that the protein molecules cause some disruption in the structure of the matrix. Small differences between the profiles can also be also seen in the case of the T15a10-100 tablets, so the rotation speed influences the release process of α-CD (Figure 3c ). The erosion process is clearly faster when the stirring speed is 100 rpm instead of 25 rpm. Nevertheless, the differences in these profiles are not very significant and the tablet erosion and the α-CD release profiles can be considered equivalent in all these cases.
The f 1 /f 2 comparison factors for the release of α-CD and the erosion curves for the tablets can be seen in Table S2 (Supporting Information). As can be seen all values of the f 1 factors are lower than 15 and the values of f 2 are higher than 50. Therefore the erosion and α-CD release curves can be considered equivalent. Thus, the release of α-CD, being a component of the matrices, can be used as an indicator of the tablet erosion.
It has to be added that these erosion studies were not carried out for T25a10 tablets because they were too soft and difficult to handle when removed from the bath, in order to be dried and weighed.
Figures 4a and 4b show the release of Trp and α-CD from T15a10 and T25a10 tablets. It is has to noticed that the differences in the profiles of Trp and α-CD means that the two release processes do not occur simultaneously as in the case of gels. Another observation is that a tablet (ca. 1g) shows a sustained release for a time as long as that of a gel (20 g ). The release of Trp from T25a10 seems to be faster than that of T15a10, but it is important to notice that the total amount of Trp loaded in T25a10 is near half the amount of Trp in the T15a10 tablets. Despite having practically the same release profiles, T15a10 tablets are preferred because they use less amount of Tetronic 90R4
and they are more consistent. The dissolution parameters for the release of Trp from T15a10 and T25a10 tablets can be observed in Table 2 . The lower values of MDT for the release of α-CD and Trp from T25a10 indicate that the release process from these tablets is slightly faster than that of T15a10 tablets. Both types of tablets show similar DE values in the release of the substances (ca. 70%). This is consistent with the value of f 1 (lower than 15) and f 2 (higher than 50) for these curves (see Supporting Information, for the release of α-CD from T25a10 and T15a10 (Table S2 ) gels points that they can be considered equivalent too. Figure 4c shows the release of Trp from T15a10-100 (i.e. T15a10 tablets stirred at 100 rpm instead of 25 rpm). As expected, the release of α-CD and Trp is faster than the release process at 25 rpm (Figure 4b ). This is quantitatively confirmed in Table 2 , where the dissolution parameters for both substances are displayed. In addition, Table   S2 shows f 1 and f 2 factors which suggest that there are differences between the release curves of Trp and α-CD using 25 and 100 rpm for the study.
The release process for BSA from T15a10 tablets is shown in Figure 4d . The BSA protein is a considerably larger molecule, so its release is slightly slower because it needs more time to leave the matrix. It is important to notice that the amount of BSA loaded in the T15a10 tablet is much higher than that of Trp (200 vs. 30 mg). As pointed above, the release of α-CD from BSA loaded tablets is practically equivalent to its release from Trp tablets. In BSA loaded tablets, the release of α-CD is faster than the release of BSA, suggesting that BSA remains in the tablet with the poloxamine molecules while α-CD is released. As can be seen in the dissolution parameters comparison ( One last type of T15a10 tablets was prepared, using a rotary evaporator to dry out the gels instead of freeze drying them (T15a10-R). The release of Trp from these tablets is slower than the release from the freeze dried ones ( Figure 5 ). This can be due to the more compact structure of the dried gel leading to a slower dissolution process. In fact, the calculated MDT value (Table 2) was the highest of all the studied tablets.
All the release profiles were fitted to different mathematical release models ( Table 4) . T15a10 shows a higher erosion constant than that of Trp from the same tablets but the diffusional constant is higher in the second case, which indicates that the contribution of erosion is higher in the release mechanism of a big molecule. Using equations 6b and 6c, the percentage contribution of the erosional and diffusional mechanisms can be graphically seen. In all the Trp releases, the main mechanism is diffusion along the whole release process (see Supporting Information, Figure S2 ). On the other hand, the release of α-CD in all the tablets is mainly dominated by erosion ( Figure S3 ).
The release of BSA is a special case (Figure 6 ), because it starts dominated by diffusion but, after 5 hours, the erosion predominates in the process. A possible explanation for this phenomenon is that, during the first part of the release process, the BSA molecules that are located in the external parts of the tablet can diffuse easily. Once these molecules have been released, the BSA molecules in the interior can not diffuse that fast, so the tablet must be eroded in order to deliver the rest. It has to be added that, as occurs with other surfactants 32 , BSA is also partially denatured by these amphiphilic block copolymers. This fact became evident when the quenching of the BSA fluorescence was studied in order to quantify the amount of BSA released. It was found that the poloxamine molecules that come into the solution when the matrix is eroded are responsible for an attenuation in the fluorescence of the protein. This quenching process corresponds to that of a denatured BSA (see Supporting Information, Figure S4 ) 33 . The reversibility of a possible denaturation process caused by the constituents of the delivery matrix will be obviously an important concern when a protein is the substrate in these devices.
Finally, the last model tested was the Hopfenberg equation. This is an erosion model, so
the best values of R 2 are obtained for the release of α-CD, as it could be expected. Thus, we can conclude that the main mechanism for the release of α-CD is the erosion. The 
CONCLUSIONS
Two different types of 90R4/α-CD matrices were evaluated as potentially drug delivery systems, namely gels and tablets. While 90R4/α-CD gels seem to be good sustained delivery devices, the amount of gel needed could be excessive for some applications.
Nevertheless, this could be a promising delivery device for transdermal devices. On the other hand, tablets made by compression of freeze dried 90R4/α-CD gels release the tested substances in an appropriate fashion using smaller amounts of matrix than the parent gels.
Different drug release mathematical equations were applied to the release profiles of the tablets. After analyzing the results, we can conclude that the release process can be tailored by controlling parameters such as the matrix composition, the stirring speed in the release assay, the nature of the molecule to be released or the gel drying process.
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Tablet preparation
The tablets can be easily prepared using a Specac evacuable pellet die: the required amount of lyophilized gel (ca. 1 g) is placed using two polyethylene discs as spacers (to avoid sticking) between the plunger and the die stainless steel pellet (13 mm diameter).
Handling it with care, a Perkin Elmer hydraulic press can be used to compress the tablets, provided that a minimal pressure is applied to avoid loss of gel by leaking.
Nevertheless, a better procedure can be described as follows: a load of ca. 2 kg (i.e. 
The samples collected by the dissolution testing device were evaluated both by UV-vis at 280 nm and by fluorescence emission at 341 nm (excitation at 280 nm). With these data, the following equations are obtained:
UV-vis:
Fluorescence:
where K Q is the quenching Stern-Volmer constant at room temperature and I Q is the actual intensity measured for each sample and I f would be that in the absence of the quencher, i.e. the one we have in the calibration curve.
Using the constants from the UV-vis calibration curves (K UV (Active) and K UV 
